KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to -$88.0 million.

  • AbbVie's Other Working Capital Changes rose 4210.53% to -$88.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $269.0 million, marking a year-over-year increase of 12231.4%. This contributed to the annual value of -$361.0 million for FY2024, which is 29202.13% down from last year.
  • As of Q3 2025, AbbVie's Other Working Capital Changes stood at -$88.0 million, which was up 4210.53% from -$371.0 million recorded in Q2 2025.
  • In the past 5 years, AbbVie's Other Working Capital Changes ranged from a high of $628.0 million in Q1 2025 and a low of -$452.0 million during Q2 2023
  • Its 5-year average for Other Working Capital Changes is $24.1 million, with a median of -$25.0 million in 2024.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 310000.0% in 2021, then tumbled by 138400.0% in 2025.
  • AbbVie's Other Working Capital Changes (Quarter) stood at -$265.0 million in 2021, then soared by 176.98% to $204.0 million in 2022, then skyrocketed by 185.29% to $582.0 million in 2023, then plummeted by 82.82% to $100.0 million in 2024, then crashed by 188.0% to -$88.0 million in 2025.
  • Its Other Working Capital Changes stands at -$88.0 million for Q3 2025, versus -$371.0 million for Q2 2025 and $628.0 million for Q1 2025.